coactivator p300
Recently Published Documents


TOTAL DOCUMENTS

85
(FIVE YEARS 4)

H-INDEX

39
(FIVE YEARS 1)

2021 ◽  
Author(s):  
Jonathan P. Karr ◽  
John J. Ferrie ◽  
Robert Tjian ◽  
Xavier Darzacq

How distal cis-regulatory elements (e.g., enhancers) communicate with promoters remains an unresolved question of fundamental importance. Although transcription factors and cofactors are known to mediate this communication, the mechanism by which diffusible molecules relay regulatory information from one position to another along the chromosome is a biophysical puzzle—one that needs to be revisited in light of recent data that cannot easily fit into previous solutions. Here we propose a new model that diverges from the textbook enhancer–promoter looping paradigm and offer a synthesis of the literature to make a case for its plausibility, focusing on the coactivator p300.


2021 ◽  
Vol 11 ◽  
Author(s):  
Sheng-Hui Lan ◽  
Shu-Ching Lin ◽  
Wei-Chen Wang ◽  
Yu-Chan Yang ◽  
Jenq-Chang Lee ◽  
...  

Many studies reported that microRNAs (miRNAs) target autophagy-related genes to affect carcinogenesis, however, autophagy-deficiency-related miRNA dysfunction in cancer development remains poorly explored. During autophagic progression, we identified miR-449a as the most up-regulated miRNA. MiR-449a expression was low in the tumor parts of CRC patient specimens and inversely correlated with tumor stage and metastasis with the AUC (area under the curve) of 0.899 and 0.736 as well as poor overall survival rate, indicating that miR-449a has the potential to be a prognostic biomarker. In the same group of CRC specimens, low autophagic activity (low Beclin 1 expression and high p62 accumulation) was detected, which was significantly associated with miR-449a expression. Mechanistic studies disclosed that autophagy upregulates miR-449a expression through degradation of the coactivator p300 protein which acetylates the transcription factor Forkhead Box O1 (FoxO1). Unacetylated FoxO1 translocated to the nucleus and bound to the miR-449a promoter to drive gene expression. Either activation of autophagy by the inducer or overexpression of exogenous miR-449a decreases the expression of target gene LEF-1 and cyclin D1, which lead to decreased proliferation, colony formation, migration, and invasion of CRC cells. Autophagy-miR-449a-tartet genes mediated suppression of tumor formation was further confirmed in the xenograft mouse model. In conclusion, this study reveals a novel mechanism wherein autophagy utilizes miR-449a-LEF1-cyclin D1 axis to suppress CRC tumorigenesis. Our findings open a new avenue toward prognosis and treatment of CRC patients by manipulating autophagy-miR-449a axis.


2021 ◽  
Author(s):  
Liang Ma ◽  
Zeyue Gao ◽  
Jiegen Wu ◽  
Bijunyao Zhong ◽  
Yuchen Xie ◽  
...  

Biochemistry ◽  
2019 ◽  
Vol 58 (32) ◽  
pp. 3434-3443 ◽  
Author(s):  
Raka Ghosh ◽  
Stephanie Kaypee ◽  
Manidip Shasmal ◽  
Tapas K. Kundu ◽  
Siddhartha Roy ◽  
...  

2016 ◽  
Vol 27 (15) ◽  
pp. 2479-2492 ◽  
Author(s):  
Phillip M. Pifer ◽  
Joshua C. Farris ◽  
Alyssa L. Thomas ◽  
Peter Stoilov ◽  
James Denvir ◽  
...  

Developmental morphogenesis and tumor progression require a transient or stable breakdown of epithelial junctional complexes to permit programmed migration, invasion, and anoikis resistance, characteristics endowed by the epithelial–mesenchymal transition (EMT). The epithelial master-regulatory transcription factor Grainyhead-like 2 (GRHL2) suppresses and reverses EMT, causing a mesenchymal–epithelial transition to the default epithelial phenotype. Here we investigated the role of GRHL2 in tubulogenesis of Madin–Darby canine kidney cells, a process requiring transient, partial EMT. GRHL2 was required for cystogenesis, but it suppressed tubulogenesis in response to hepatocyte growth factor. Surprisingly, GRHL2 suppressed this process by inhibiting the histone acetyltransferase coactivator p300, preventing the induction of matrix metalloproteases and other p300-dependent genes required for tubulogenesis. A 13–amino acid region of GRHL2 was necessary for inhibition of p300, suppression of tubulogenesis, and interference with EMT. The results demonstrate that p300 is required for partial or complete EMT occurring in tubulogenesis or tumor progression and that GRHL2 suppresses EMT in both contexts through inhibition of p300.


2015 ◽  
Vol 5 (1) ◽  
Author(s):  
Jihong Chen ◽  
Yingjian Wang ◽  
Munerah Hamed ◽  
Natascha Lacroix ◽  
Qiao Li

2015 ◽  
Vol 14 (6) ◽  
pp. 1276-1285 ◽  
Author(s):  
Sagar Uttarkar ◽  
Sandeep Dukare ◽  
Bertan Bopp ◽  
Michael Goblirsch ◽  
Joachim Jose ◽  
...  

2013 ◽  
Vol 27 (8) ◽  
pp. 1322-1332 ◽  
Author(s):  
Ling He ◽  
Jia Cao ◽  
Shumei Meng ◽  
Anlin Ma ◽  
Sally Radovick ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document